Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.

Elamin, Yasir Y; Robichaux, Jacqulyne P; Carter, Brett W; Altan, Mehmet; Gibbons, Don L; Fossella, Frank V; Lam, Vincent K; Patel, Anisha B; Negrao, Marcelo V; Le, Xiuning; Mott, Frank E; Zhang, Jianjun; Feng, Lei; Blumenschein, George; Tsao, Anne S; Heymach, John V

Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.

Elamin, Yasir Y; Robichaux, Jacqulyne P; Carter, Brett W; Altan, Mehmet; Gibbons, Don L; Fossella, Frank V; Lam, Vincent K; Patel, Anisha B; Negrao, Marcelo V; Le, Xiuning; Mott, Frank E; Zhang, Jianjun; Feng, Lei; Blumenschein, George; Tsao, Anne S; Heymach, John V.

Afiliação

Elamin YY; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Robichaux JP; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Carter BW; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.
Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Fossella FV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Lam VK; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Patel AB; Department of Medicine, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD.
Negrao MV; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Le X; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Mott FE; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Zhang J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Feng L; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blumenschein G; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Tsao AS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

J Clin Oncol ; 40(7): 702-709, 2022 03 01.

Article em En | MEDLINE | ID: mdl-34550757

Assuntos

Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; Éxons; Neoplasias Pulmonares/tratamento farmacológico; Mutação; Quinazolinas/uso terapêutico; Receptor ErbB-2/genética; Idoso; Carcinoma Pulmonar de Células não Pequenas/genética; Carcinoma Pulmonar de Células não Pequenas/patologia; Feminino; Seguimentos; Humanos; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patologia; Masculino; Pessoa de Meia-Idade; Prognóstico; Taxa de Sobrevida

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Éxons / Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Neoplasias Pulmonares / Mutação Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google